Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Sale of Interest in China Cord Blood Corporation

Represented China Cord Blood Corporation (CCBC) in connection with the sale by Golden Meditech Holdings Ltd. of CCBC’s 7 percent senior convertible note, due 2017 in aggregate principal amount of US$50 million, to Magnum Opus International Holdings Ltd. and Cordlife Group Ltd. for approximately US$88 million.